| Primary |
| Frontal Lobe Epilepsy |
100.0% |
|
| Frontal Lobe Epilepsy |
100.0% |
|
| Secondary |
| Product Used For Unknown Indication |
37.0% |
| Insomnia |
19.6% |
| Non-small Cell Lung Cancer |
13.0% |
| Prophylaxis |
8.7% |
| Hypertension |
6.5% |
| Drug Exposure During Pregnancy |
4.3% |
| Epilepsy |
2.2% |
| Essential Hypertension |
2.2% |
| Infertility |
2.2% |
| Off Label Use |
2.2% |
| Polycystic Ovaries |
2.2% |
|
| Death |
42.9% |
| Exomphalos |
14.3% |
| Infection |
14.3% |
| Rash Macular |
14.3% |
| Tongue Haemorrhage |
14.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
47.0% |
| Product Used For Unknown Indication |
27.6% |
| Rheumatoid Arthritis |
3.8% |
| Renal Failure Chronic |
3.2% |
| Peritoneal Dialysis |
1.9% |
| Pain |
1.9% |
| Prophylaxis Against Transplant Rejection |
1.7% |
| Renal Transplant |
1.7% |
| Non-small Cell Lung Cancer |
1.7% |
| Nausea |
1.6% |
| Hypertension |
1.0% |
| Depression |
0.9% |
| Prophylaxis |
0.9% |
| Insomnia |
0.9% |
| Diarrhoea |
0.8% |
| Dyspnoea |
0.8% |
| Essential Hypertension |
0.7% |
| Pruritus |
0.6% |
| Acute Generalised Exanthematous Pustulosis |
0.6% |
| Anxiety |
0.6% |
|
| Cardiac Arrest |
10.0% |
| Peritonitis |
10.0% |
| Vomiting |
10.0% |
| Septic Shock |
8.7% |
| Myocardial Infarction |
6.7% |
| Sepsis |
6.0% |
| Hypotension |
5.3% |
| Thrombocytopenia |
4.7% |
| Pyrexia |
4.0% |
| Respiratory Depression |
4.0% |
| Urinary Tract Infection |
4.0% |
| Somnolence |
3.3% |
| Tremor |
3.3% |
| Venous Occlusion |
3.3% |
| Weight Decreased |
3.3% |
| Diarrhoea |
2.7% |
| Haemoglobin Decreased |
2.7% |
| Peritoneal Dialysis Complication |
2.7% |
| Rash Erythematous |
2.7% |
| Toxic Epidermal Necrolysis |
2.7% |
|
